Influence of age, sex, body size, smoking, and β blockade on key gas exchange exercise parameters in an adult population

European Journal of Preventive Cardiology

Volumn 17, Issue 4, 2010, Pages 469-476

  Sven, Gläser ^a   Koch, Beate ^a   Ittermann, till ^b   Christoph, Schäper ^a   Marcus, Dörr ^a   Felix, Stephan B ^a   Henry, Völzke ^b   Ewert, Ralf ^a   Hansen, James E ^c  

^a Pulmonary Medicine and Infectious Diseases   (United States)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

exercise; obesity; smoking; ventilation; blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY SIZE; BODY WEIGHT; CARDIOPULMONARY EXERCISE TEST; CIGARETTE SMOKING; FEMALE; GAS EXCHANGE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; REFERENCE VALUE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY SIZE; CROSS-SECTIONAL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GERMANY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; PULMONARY GAS EXCHANGE; REFERENCE VALUES; SEX FACTORS; SMOKING; TIDAL VOLUME;

EID: 77955468375     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e328336a124     Document Type: Article

References (27)

1. Piepoli MF, Corra U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Recommendations for performance and interpretation. Eur J Cardiovasc Prev Rehabil 2006; 13: 10–12.
2. Arena R, Guazzi M, Myers J, Ann Peberdy M. Prognostic characteristics of cardiopulmonary exercise testing in heart failure: comparing American and European models. Eur J Cardiovasc Prev Rehabil 2005; 12: 562–567.
3. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of exercise testing and interpretation: including pathophysiology and clinical applications. 4th ed. Baltimore, Maryland, USA: Lippincott Williams and Wilkins; 2004.
4. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129 (2 Pt 2):S49–S55.
5. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131: 700–708.
6. Sue DY, Hansen JE. Normal values in adults during exercise testing. Clin Chest Med 1984; 5: 89–98.
7. Fairbarn MS, Blackie SP, McElvaney NG, Wiggs BR, Pare PD, Pardy RL. Prediction of heart rate and oxygen uptake during incremental and maximal exercise in healthy adults. Chest 1994; 105: 1365–1369.
8. Koch B, Schaper C, Ittermann T, Spielhagen T, Dorr M, Volzke H, et al Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J 2009; 33: 389–397.
9. Beloka S, Gujic M, Deboeck G, Niset G, Ciarka A, Argacha JF, et al Beta-adrenergic blockade and metabo-chemoreflex contributions to exercise capacity. Med Sci Sports Exerc 2008; 40: 1932–1938.
10. John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, et al Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001; 46: 186–194.
11. Keil U, Stieber J, Doring A, Chambless L, Hartel U, Filipiak B, et al The cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/85. Acta Med Scand Suppl 1988; 728: 119–128.
12. World Health Organisation. ATC index with DDDs annually guidelines for ATC classification and DDD assignment. In: WHO Collaborating Centre for drug Statistics Methodology; Oslo, Norway 2008.
13. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5–40.
14. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, et al Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101: 2803–2809.
15. Koenker R. Quantile regression: economic society monograph serie. New York: Cambridge University Press; 2005.
16. Jones NL, Summers E, Killian KJ. Influence of age and stature on exercise capacity during incremental cycle ergometry in men and women. Am Rev Respir Dis 1989; 140: 1373–1380.
17. Wolk R, Johnson BD, Somers VK, Allison TG, Squires RW, Gau GT, Olson LJ. Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure. J Card Fail 2005; 11: 333–339.
18. Unverdorben M, Der Bijl A, Potgieter L, Liang Q, Meyer BH, Roethig HJ. Effects of levels of cigarette smoke exposure on symptom-limited spiroergometry. Prev Cardiol 2007; 10: 83–91.
19. Hirsch GL, Sue DY, Wasserman K, Robinson TE, Hansen JE. Immediate effects of cigarette smoking on cardiorespiratory responses to exercise. J Appl Physiol 1985; 58: 1975–1981.
20. Koike A, Weiler-Ravell D, McKenzie DK, Zanconato S, Wasserman K. Evidence that the metabolic acidosis threshold is the anaerobic threshold. J Appl Physiol 1990; 68: 2521–2526.
21. Volzke H, Neuhauser H, Moebus S, Baumert J, Berger K, Stang A, et al Urban-rural disparities in smoking behaviour in Germany. BMC Public Health 2006; 6: 146.
22. Volzke H, Neuhauser H, Moebus S, Baumert J, Berger K, Stang A, et al Rauchen: Regionale Unterschiede in Deutschland. [Urban–rural disparities in smoking behaviour in Germany]. Dtsch Arztebl 2006; 103: 2784–2790.
23. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741–750.
24. Wasserman K, Sun XG, Hansen JE. Effect of biventricular pacing on the exercise pathophysiology of heart failure. Chest 2007; 132: 250–261.
25. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211–277.
26. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973; 85: 546–562.
27. Mondolfi RN, Jones TM, Hyre AD, Raggi P, Muntner P. Comparison of percent of United States adults weighing ≥ 300 pounds (136 kg) in three time periods and comparison of five atherosclerotic risk factors for those weighing ≥ 300 pounds to those 300 pounds. Am J Cardiol 2007; 100: 1651–1653.